Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- BIRK +4.8% (guidance), ACN +1.2%, SCS +1%
Other news:
- PEPG +151.1% (prices offering of 31.25 mln shares of common stock at $3.20 per share)
- EVAX +43.6% (out-licenses vaccine candidate EVX-B3 to MSD (MRK))
- IMRX +21.9% (results from phase 2a trial of Atebimetinib + mGnP; also public offering and concurrent private placement; prices 18,959,914 shares of common stock at $9.23 per share; concurrently, Sanofi (SNY) agrees to purchase 2,708,559 shares of Immuneering's common stock at $9.23 per share in separate transaction)
- QURE +10.3% ($200 mln public offering of common shares)
- CIFR +6.1% (signs 168 mw, 10-year AI Hosting agreement with Fluidstack; announces proposed private offering of $800 million of 0.00% convertible senior notes)
- DGNX +4.8% (update on acquisition strategy)
- KALV +3.9% (prices offering of $125.0 mln of 3.250% Convertible Senior Notes due 2031)
- PSEC +3.1% (disclosure of CEO insider purchase) SMA +2% (to combine with Argus Professional Storage Management)
- SCLX +1.4% (announces closing of previously announced non-dilutive value enhancing transaction with an institutional investor for the exchange of $200 million of common stock of Semnur Pharmaceuticals (SMNR) held by Scilex Holding Company for $200 million in bitcoin)
- LSPD +1.3% (announces strategic appointments to its Board to further position the company for profitable growth)